Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
1123 RESULTS FOUND
Docket No. FDA-2018-D-0787: Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank
November 9, 2018 | Comments
FDA Advisory Committee Meetings and the Role of the Industry Representative Questions And Answers
October 30, 2018 | Guidance
AdvaMed Comments on Docket No. FDA-2018-N-0628: Medical Device Submissions: Amending Premarket Regulations That Require Multiple Copies and Specify Paper Copies To Be Allowed in Electronic Format
October 29, 2018 | Comments
AdvaMed Statement Re: OIG–0803–N: Request for Information Regarding the Anti-Kickback Statute and Beneficiary Inducements CMP
October 26, 2018 | Letter
Physician Service Market Analysis Report
October 22, 2018 |
AdvaMed Comments on Docket No. FDA–2018–D–2896: Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment; Draft Guidance for Industry; Availability
October 19, 2018 | Comments
Accountable Care Organizations (ACOs)—Pathways to Success
October 16, 2018 | Letter
AdvaMed Comments on Docket No. FDA-2018-N-3066: Medical Devices; Classification of Accessories Distinct From Other Devices; Proposed List of Accessories Suitable for Class I; Request for Comments
October 16, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2018-D-2310: Process to Request a Review of FDA's Decision Not to Issue Certain Export Certificates for Devices; Draft Guidance for Industry and Food and Drug Administration Staff
October 15, 2018 | Comments
Medical Device Follow Up Letter
October 11, 2018 | Letter
Quality Culture Playbook
October 8, 2018 | Presentation
Burningham v Wright Medical - Amici Brief
October 8, 2018 |
Letter to Congress Urging Action Signed by 17 Organizations
October 1, 2018 | Letter
Celebrating Diversity At The MedTech Conference
September 21, 2018 | Fact Sheet
Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center
September 21, 2018 | Letter
AdvaMed Comments On Docket No. FDA-2017-N-4301: Fostering Medical Innovation: A Plan For Digital Health Devices; Software Precertification Pilot Program
September 20, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2018-N-0404: Pediatric Medical Device Development Public Meeting; Request for Public Comments
September 14, 2018 | Comments
AdvaMed Statement on Energy and Commerce Health Subcommittee Hearing on VBHC Barriers
September 13, 2018 | Statement
Revisions to Payment Policies Under the PFS and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program; and Medicaid Promoting Interoperability Program (CMS-1693-P)
September 10, 2018 | Letter
AdvaMed Comments on Docket No. FDA-2018-N-1621: Patient-Focused Drug Development for Chronic Pain; Notice of Public Meeting; Request for Comments
September 10, 2018 | Comments
CY 2019 Home Health Prospective Payment Rate Update and Other Home Health Changes
August 30, 2018 | Letter
End-Stage Renal Disease Prospective Payment System, DMEPOS, CBP and Fee Schedule Amounts, and Technical Amendments to Correct Existing Regulations
August 27, 2018 | Letter
AdvaMedDx Comments on FDA Technical Assistance (TA) on Diagnostic Accuracy and Innovation Act (DAIA) House Discussion Draft
August 27, 2018 | Comments
Perspectives and Good Practices for AI and Continuous Learning Systems in Healthcare
August 24, 2018 | White Paper
GmLP Checklist
August 24, 2018 | Guidance

Pages